People taking GLP-1 receptor agonists like semaglutide and tirzepatide reported a significantly higher rate of nail detachment and discoloration compared to patients with obesity or type 2 diabetes who never used the drugs, according to an international survey presented at the European Academy of Dermatology and Venereology Congress 2026 in Vienna.
International Survey Results Show Nail Detachment Rates Four Times Higher Among Users
The early survey data revealed that 39% of GLP-1 users experienced nail detachment, a condition where the nail pulls away from the nail bed. That figure compares with just 9% of non-users in the control group, representing a more than fourfold difference, according to Medical Daily. Overall, two-thirds of the 575 GLP-1 medication users tracked in the study reported at least one nail issue.
Nail discoloration also emerged more frequently among those on the medications. The survey recorded discoloration in 46% of GLP-1 users, compared to 17% of the 1,329 non-users in the control pool, which included individuals diagnosed with obesity and type 2 diabetes.
Hair Loss and Scalp Inflammation Add to Reported Side Effects
A companion study focusing on the scalp found that GLP-1 users faced elevated risks of hair thinning and loss. Unusual hair loss was reported by 50% of users compared to 34% of controls, while 42% noted a loss of hair volume or density, Medical Daily reported. Looking specifically at hair loss that started after treatment began, 26% of users reported the symptom versus 12% of non-users.
Most GLP-1 users who experienced hair loss also reported scalp problems, including redness, itching, or flaky skin, according to findings covered by BBC Science Focus. Study co-author Dr. Bruno Halioua noted that scalp redness was about three times more common among users, suggesting an inflammatory component that goes beyond typical post-weight-loss shedding.
Researchers Examine Rapid Weight Loss and Nutritional Deficiencies as Potential Factors
Dermatologists emphasize that the survey findings are early and do not definitively prove the medications directly cause the nail and hair changes. Dr. Charles Taïeb, the lead author of the nail study, stated that the research establishes a clear association but noted that not everything happening during treatment stems directly from the drug itself.
BBC Science Focus reported that factors like rapid weight loss, reduced food intake, and associated deficiencies in key nutrients like zinc, iron, and protein can disrupt nail growth. However, European Academy of Dermatology and Venereology press materials noted that the higher frequency of nail problems did not appear to be fully explained by weight loss alone.
Frequently Asked Questions About GLP-1 Nail and Hair Symptoms
Should patients stop taking GLP-1 medications if they notice nail detachment?
No. Medical experts and study authors stress that patients should not stop taking an effective GLP-1 prescription on their own initiative. Dr. Christos Tziotzios, a consultant dermatologist at Guy’s and St Thomas’ Hospitals in London who was not involved in the research, noted that the benefits of the drugs outweigh these side effects.
What specific nail and scalp changes did the 2026 EADV study track?
Presented at the European Academy of Dermatology and Venereology Congress 2026 in Vienna, the survey tracked 575 GLP-1 users against 1,329 controls. It recorded that 39% of users suffered nail detachment, 46% saw nail discoloration, 26% experienced new hair loss after starting treatment, and many reported scalp redness and irritation.
When should a patient seek immediate medical attention for nail changes?
Medical Daily reports that patients should consult a physician promptly if nail changes become painful, red, swollen, or begin draining pus, as these symptoms can signal an underlying infection.
Worth a look